Two Scripps Research scientists named 2026 Canada Gairdner International Award Laureates
Two Scripps Research scientists, John Yates III and Jeffery Kelly, have been named 2026 Canada Gairdner International Award Laureates for their contributions to biomedical science. Yates pioneered shotgun proteomics, while Kelly's research led to the discovery of tafamidis, a drug that slows the progression of transthyretin cardiomyopathy and polyneuropathy.
Scripps Research professors John Yates III and Jeffery Kelly have been named 2026 Canada Gairdner International Award Laureates. The Canada Gairdner International Award recognizes researchers whose discoveries have made a major impact on scientific progress and human health. Yates is a foundational architect of modern proteomics, and his work on shotgun proteomics enabled automated, large-scale identification of proteins from complex biological samples using mass spectrometry. Kelly's research into protein aggregation has helped illuminate the molecular basis of protein aggregation diseases such as Alzheimer's disease and transthyretin amyloidosis. Kelly's laboratory discovered tafamidis, a drug that slows the progression of transthyretin cardiomyopathy and polyneuropathy and is taken by approximately 70,000 patients worldwide. The Gairdner Foundation has bestowed 434 awards on laureates from over 40 countries, with 103 past laureates going on to receive the Nobel Prize.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.